deltatrials
Completed PHASE4 NCT00344760

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy

Viral Decay Kinetics During Induction Therapy With or Without the Use of Enfuvirtide in HAART-naÃ-ve Patients With Advanced HIV

Sponsor: University of Maryland, Baltimore

Conditions HIV Infections
Interventions Efavirenz, lamivudine, and tenofovir Enfuvirtide
Updated 8 times since 2017 Last updated: May 6, 2021 Started: Jan 31, 2005 Primary completion: Mar 31, 2007 Completion: Mar 31, 2007

This PHASE4 trial investigates HIV Infections and is currently completed. University of Maryland, Baltimore leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jun 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jun 2021 [monthly]

    Completed PHASE4

  5. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 3 earlier versions

  1. Jun 2018 — Sep 2019 [monthly]

    Completed PHASE4

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Maryland, Baltimore
Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Baltimore, United States